MAZE

NASDAQ · Equity

Maze Therapeutics, Inc. Common Stock

US Healthcare Biotechnology

Latest week
29 May 2026
Close
26.460000
Fair value
24.589638
Expectation
Negative 35.18%
Weekly Close Trend Line Fair Value Activity Lines

Chart Summary

Key Points

Week Ending
29 May 2026
Latest Close
26.46
12-Week Change
-47.30%
Trend Signal
Inactive
Expectation
Negative 35.18%
Signal Weeks
3 of 12
Vs Trend Line
Below
Vs Fair Value
Above
Relative Strength
-25.35
Market Dynamics
-1.37

Over the latest 12 completed weeks ending 2026-05-29, MAZE fell 47.30%, moving from 50.21 to 26.46. The latest weekly close is below the Trend Line and above Fair Value. Trend Signal is inactive on the latest week and was active in 3 of the last 12 weeks. Relative Strength is -25.35 and has softened across the 12-week window. Market Dynamics is -1.37 on the latest week. Expectation is negative at 35.18%.